These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31292831)

  • 1. Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells.
    Ramzan AA; Bitler BG; Hicks D; Barner K; Qamar L; Behbakht K; Powell T; Jansson T; Wilson H
    Mol Cell Biochem; 2019 Nov; 461(1-2):37-46. PubMed ID: 31292831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
    Fairaq A; Shawky NM; Osman I; Pichavaram P; Segar L
    Pharmacol Res; 2017 May; 119():289-302. PubMed ID: 28237515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase.
    Bui KC; Nguyen TML; Barat S; Scholta T; Xing J; Bhuria V; Sipos B; Wilkens L; Nguyen LT; Le HS; Velavan TP; Bozko P; Plentz RR
    Curr Med Chem; 2024; 31(28):4534-4548. PubMed ID: 38361349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin Receptor Agonist Effectively Suppresses Hepatocellular Carcinoma Growth.
    Nguyen MLT; Pham C; Pham VT; Nham PLT; Ta BT; Le DT; Le QV; Hoang XC; Bozko P; Nguyen LT; Bui KC
    Cell Biochem Biophys; 2024 Jun; 82(2):687-695. PubMed ID: 38243102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AdipoRon Protects Against Secondary Brain Injury After Intracerebral Hemorrhage via Alleviating Mitochondrial Dysfunction: Possible Involvement of AdipoR1-AMPK-PGC1α Pathway.
    Yu J; Zheng J; Lu J; Sun Z; Wang Z; Zhang J
    Neurochem Res; 2019 Jul; 44(7):1678-1689. PubMed ID: 30982205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.
    Zhang Y; Zhao J; Li R; Lau WB; Yuan YX; Liang B; Li R; Gao EH; Koch WJ; Ma XL; Wang YJ
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(3):E275-82. PubMed ID: 26037251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
    Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
    J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin receptor agonist AdipoRon suppresses adipogenesis in C3H10T1/2 cells through the adenosine monophosphate‑activated protein kinase signaling pathway.
    Wang SJ; Lu WY; Liu KY
    Mol Med Rep; 2017 Nov; 16(5):7163-7169. PubMed ID: 28901521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin receptor agonist AdipoRon attenuates calcification of osteoarthritis chondrocytes by promoting autophagy.
    Duan ZX; Tu C; Liu Q; Li SQ; Li YH; Xie P; Li ZH
    J Cell Biochem; 2020 Jun; 121(5-6):3333-3344. PubMed ID: 31898335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AdipoRon, an adiponectin receptor agonist, protects contrast-induced nephropathy by suppressing oxidative stress and inflammation via activation of the AMPK pathway.
    Gu D; Shi Y; Gong Z; Xia T; Ren H; He D; Yang J; Han Y; Zeng C
    Clin Exp Nephrol; 2020 Nov; 24(11):989-998. PubMed ID: 32734507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway.
    Liu B; Liu J; Wang JG; Liu CL; Yan HJ
    Exp Neurol; 2020 May; 327():113249. PubMed ID: 32070713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncovering the connection between obesity and thyroid cancer: the therapeutic potential of adiponectin receptor agonist in the AdipoR2-ULK axis.
    Li C; Zhang J; Dionigi G; Liang N; Guan H; Sun H
    Cell Death Dis; 2024 Sep; 15(9):708. PubMed ID: 39349421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adiponectin Receptor Agonist AdipoRon Inhibits the Proliferation of Myeloma Cells via the AMPK/Autophagy Pathway].
    Wang SJ; Wang C; Wang WQ; Hao QQ; Liu YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):171-176. PubMed ID: 32027272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adiponectin agonist, AdipoRon, inhibits steroidogenesis and cell proliferation in human luteinized granulosa cells.
    Grandhaye J; Hmadeh S; Plotton I; Levasseur F; Estienne A; LeGuevel R; Levern Y; Ramé C; Jeanpierre E; Guerif F; Dupont J; Froment P
    Mol Cell Endocrinol; 2021 Jan; 520():111080. PubMed ID: 33189865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of adiponectin receptors has negative impact on muscle mass in C2C12 myotubes and fast-type mouse skeletal muscle.
    Ito R; Higa M; Goto A; Aoshima M; Ikuta A; Ohashi K; Yokoyama S; Ohno Y; Egawa T; Miyata H; Goto K
    PLoS One; 2018; 13(10):e0205645. PubMed ID: 30308063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoring diabetes-induced autophagic flux arrest in ischemic/reperfused heart by ADIPOR (adiponectin receptor) activation involves both AMPK-dependent and AMPK-independent signaling.
    Wang Y; Liang B; Lau WB; Du Y; Guo R; Yan Z; Gan L; Yan W; Zhao J; Gao E; Koch W; Ma XL
    Autophagy; 2017; 13(11):1855-1869. PubMed ID: 28825851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis.
    Akimoto M; Maruyama R; Kawabata Y; Tajima Y; Takenaga K
    Cell Death Dis; 2018 Jul; 9(8):804. PubMed ID: 30038429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C; Liu VW; Chan DW; Yao KM; Ngan HY
    Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner.
    Rattan R; Giri S; Hartmann LC; Shridhar V
    J Cell Mol Med; 2011 Jan; 15(1):166-78. PubMed ID: 19874425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
    Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
    J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.